Cargando…

Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis

BACKGROUND: Severe renal manifestation of systemic lupus erythematosus (SLE) is not uncommon and is associated with an indeterminate prognosis. Complete remission can be obtained, however, at least in the young when chronic lesions are absent and adequate anti-inflammatory therapy is immediately ini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Sophia, Benz, Kerstin, Sauerstein, Katja, Amann, Kerstin, Dötsch, Jörg, Dittrich, Katalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459702/ https://www.ncbi.nlm.nih.gov/pubmed/22867270 http://dx.doi.org/10.1186/1471-2369-13-81

Ejemplares similares

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
por: Kanodia, Kamal V, et al.
Publicado: (2008)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption
por: Štambuk, Sandra Karanović, et al.
Publicado: (2023)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis
por: Romick-Rosendale, Lindsey E, et al.
Publicado: (2011)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
por: Chen, Dong-Ni, et al.
Publicado: (2018)

Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
por: Olson, S. W., et al.
Publicado: (2017)

Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis
por: Gonzalo, Elena, et al.
Publicado: (2012)

Differing environmental risk factors for membranous versus proliferative lupus nephritis
por: Dooley, MA, et al.
Publicado: (2012)

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial
por: Galbraith, Lauren, et al.
Publicado: (2014)

Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial
por: Gheet, Fatma Sayed, et al.
Publicado: (2023)

Long-term renal outcomes of patients with non-proliferative lupus nephritis
por: Kang, Eun-Song, et al.
Publicado: (2023)

LHCb Longterm Plans
por: Parkes, Chris
Publicado: (2017)

Developing consensus treatment plans for proliferative lupus nephritis in childhood-onset systemic lupus erythematous
por: Mina, Rina, et al.
Publicado: (2012)

CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis
por: Olmes, Gregor, et al.
Publicado: (2016)

Long-term predictive value of acute kidney injury classification in diffuse proliferative lupus nephritis with acute kidney injury
por: Chen, Tianxin, et al.
Publicado: (2020)

Cardiovascular changes in the NZB/W F1 mouse model of lupus nephritis
por: Böhme, Romy, et al.
Publicado: (2023)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
por: Häyry, Aliisa, et al.
Publicado: (2022)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
por: Marín-Rosales, Miguel, et al.
Publicado: (2022)

Treatment Outcomes of Proliferative vs. Non-proliferative Adult Lupus Nephritis: A 10-Year Follow-Up
por: Zahab, Mohamed, et al.
Publicado: (2021)

CD107a(+) (LAMP-1) Cytotoxic CD8(+) T-Cells in Lupus Nephritis Patients
por: Wiechmann, Anika, et al.
Publicado: (2021)

The beginning of long term longterm
Publicado: (2004)

Longterm endocrine effects of cancer
por: Zacharin, Margaret
Publicado: (2013)

Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience
por: Duran, Emine, et al.
Publicado: (2022)

Transvascular kidney biopsy in adolescent patients—safe alternative to open procedures
por: Utsch, Boris, et al.
Publicado: (2020)

Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India
por: Sircar, D., et al.
Publicado: (2013)

The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
por: Dalton, Kristen, et al.
Publicado: (2010)

Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity
por: Chen, Dandan, et al.
Publicado: (2022)

Discovery of NEU1 as a candidate renal biomarker for proliferative lupus nephritis chronicity
por: Mao, Zhaomin, et al.
Publicado: (2021)

Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients
por: Touzot, Maxime, et al.
Publicado: (2017)

Idiopathic granulomatous interstitial nephritis and isolated renal sarcoidosis: Two diagnoses of exclusion
por: Janssen, Ulf, et al.
Publicado: (2021)

Contemporary estimates of the risk of end-stage renal disease in the first decade of proliferative lupus nephritis
por: Ward, MM, et al.
Publicado: (2012)

Therapeutic Implications of Renal Biopsies to Detect Proliferative Lupus Nephritis in Patients With Low-Grade Proteinuria
por: Plüß, Marlene, et al.
Publicado: (2020)

Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa
por: Sogayise, Phelisa, et al.
Publicado: (2020)

Elevated serum levels of human epididymis protein 4 in adult patients with proliferative lupus nephritis
por: Li, Liubing, et al.
Publicado: (2023)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus
por: Haddon, D. James, et al.
Publicado: (2015)

Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019)

Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
por: Caster, Dawn J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n70jm7ok8tebe99755bur0pi7b